NCT03855878
- Conditions
- Blood Protein Disorders, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
- Locations
-
- Indiana University Simon Cancer Center Indianapolis, Indiana, United States
Clinical trial condition
Monoclonal Gammopathy of Undetermined Significance
Explore clinical trials studying Monoclonal Gammopathy of Undetermined Significance. Study availability and eligibility vary by location and protocol.
82 public trials
19 recruiting studies
Monoclonal Gammopathy of Undetermined Significance trial results
NCT04615572
- Conditions
- Amyloidosis, Blood Protein Disorders, Hematologic Diseases, +16 more
- Locations
-
- University of California, Irvine Health Chao Family Comprehensive Cancer Center Orange, California, United States
- University of California, San Francisco San Francisco, California, United States
- University of Miami Sylvester Comprehensive Cancer Center Miami, Florida, United States
- Tufts Medical Center Boston, Massachusetts, United States
NCT03119883
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +15 more
- Locations
-
- Mayo Clinic in Rochester Rochester, Minnesota, United States
NCT01063907
- Conditions
- Blood Protein Disorders, Bronchial Diseases, Bronchiolitis, +28 more
- Locations
-
- Arizona Clinical Research Center, Inc. / Arizona Oncology Associates, 1825 N Kolb, Tucson, Arizona, United States
- Pacific Shores Medical Group 1043 Elm Ave, Suite 104 Long Beach, California, United States
- UCLA Medical Center Hematology / Oncology Division, 10945 Le Conte Ave #2333, Los Angeles, California, United States
- Collaborative Research Group 2320 S Seacrest Blvd, Suite 202 Boynton Beach, Florida, United States
NCT01588015
- Conditions
- Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, +198 more
- Locations
-
- City of Hope Medical Center Duarte, California, United States
NCT04439006
- Conditions
- Anemia, Anemia, Aplastic, Aplastic Anemia, +19 more
- Locations
-
- Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
NCT00424242
- Conditions
- Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +112 more
- Locations
-
- Robert H. Lurie Comprehensive Cancer Center at Northwestern University Chicago, Illinois, United States
Completed
Dalteparin to Prevent Complications in Cancer Patients Receiving Chemotherapy Through a Catheter
NCT00006083
- Conditions
- Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +94 more
- Locations
-
- Jonsson Comprehensive Cancer Center, UCLA Los Angeles, California, United States
NCT00070382
- Conditions
- Amyloidosis, Anemia, Blood Protein Disorders, +55 more
- Locations
-
- Jonsson Comprehensive Cancer Center, UCLA Los Angeles, California, United States
NCT00003687
- Conditions
- Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +93 more
- Locations
-
- Cross Cancer Institute Edmonton, Alberta, Canada
- Newfoundland Cancer Treatment and Research Foundation St. John's, Newfoundland and Labrador, Canada
- Princess Margaret Hospital Toronto, Ontario, Canada
- McGill University Montreal, Quebec, Canada